Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Covington
Federal Trade Commission
Queensland Health
Colorcon
Dow
Farmers Insurance
AstraZeneca
Moodys

Generated: February 19, 2018

DrugPatentWatch Database Preview

MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Magnesium Sulfate In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Magnesium Sulfate In Dextrose 5% In Plastic Container launch?

Magnesium Sulfate In Dextrose 5% In Plastic Container is a drug marketed by Fresenius Kabi Usa, Hospira, and Hq Spclt Pharma. and is included in three NDAs.

The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There are one hundred and thirty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.

US Patents and Regulatory Information for MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 206486-001 Mar 7, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hq Spclt Pharma MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 207349-001 Mar 2, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 020488-001 Jul 11, 1995 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER magnesium sulfate INJECTABLE;INJECTION 020488-002 Jul 11, 1995 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Citi
QuintilesIMS
Healthtrust
Boehringer Ingelheim
Baxter
Accenture
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot